Chapter One: Executive Summary

• Introduction
• Size and Growth of the Market
• Overall Market
• Antibacterials
• Systemic Antifungals
• Emerging Anti-Infective Therapies
• Anti-Infective Treatments
• Overview
• Antibacterials
• Systemic Antifungals
• Issues and Trends Affecting the Market
• Cost Containment
• Demographics
• Factors Influencing Physicians' Prescribing Practices
• Generic Competition/Patent Issues
• Research and Development
• Anti-Infective Agents: Resistance Development
• Industry Structure and Leading Competitors
• The Microbiology of Infection
• Causative Agents
• Examples of Infectious Diseases
• Scope and Methodology

Chapter Two: Introduction

• The Microbiology of Infection
• Causative Agents
• Modes of Transmission
• The Body's Defense Against Infection
• Examples of Emerging Infectious Diseases
• Acquired Immunodeficiency Syndrome (AIDS)
• Bacterial Infections
• Fungal Infections
• Miscellaneous Infectious Diseases
• Epidemiology
• Characteristics of Patient Population

Chapter Three: The Product

• Overview
• Industry Participants
• Alliances
• Types of Anti-Infective Agents
• Antibacterials
• Systemic Antifungals

Chapter Four: Issues and Trends

• Introduction
• Cost-Containment Issues
• Impact of Information Technology
• Establishment of Disease Management Programs
• Outpatient IV Therapy
• Demographics
• Issues Among Children
• Issues Among the Elderly
• Issues Among Individuals with Lowered Immunity
• Factors Influencing Physicians' Prescribing Practices
• Generic Competition and Pricing Trends and Issues
• Research and Development Trends
• Anti-Infective Therapies in Development
• Resistance Development of Anti-Infective Agents

Chapter Five: The Market

• Scope and Methodology
• Market Size and Forecast
• Background
• Revenues
• Antibacterials
• Introduction
• The Market for Antibacterials
• Segment Analysis
• Impact of New and Emerging Products Not Significant
• Beta-Lactamase Inhibitors
• Cephalosporins
• Macrolides
• Penicillins
• Quinolones
• Tetracyclines
• Miscellaneous Antibacterials
• Other Miscellaneous Antibacterials
• Systemic Antifungals
• Introduction
• Amphotericin B
• Amphotericin B Lipid and Liposomal Formulations
• Azoles
• Market Analysis
• Market Size: 1996 to 2001
• Major Competitors
• Emerging Anti-Infective Therapies

Chapter Six: Competitor Profiles

• Background
• Abbott Laboratories
• History and Lines of Business
• Anti-Infective Drugs
• Research and Development
• Corporate Strategies
• Corporate Analysis
• American Home Products Corp.
• History and Lines of Business
• Financial Information
• Anti-Infective Drugs
• Research and Development
• Corporate Strategies
• Corporate Analysis
• Bayer Corp.
• History and Lines of Business
• Financial Information
• Anti-Infective Drugs
• Research and Development
• Corporate Strategies
• Corporate Analysis
• Bristol-Myers Squibb Co.
• History and Lines of Business
• Financial Information
• Anti-Infective Drugs
• Research and Development
• Corporate Strategies
• Eli Lilly and Co.
• History and Lines of Business
• Financial Information
• Anti-Infective Drugs
• Research and Development
• Corporate Strategies
• Corporate Analysis
• Hoffman-La Roche, Inc.
• History and Lines of Business
• Financial Information
• Anti-Infective Drugs
• Research and Development
• Corporate Strategies
• Corporate Analysis
• Johnson & Johnson
• History and Lines of Business
• Financial Information
• Anti-Infective Drugs
• Research and Development
• Corporate Strategies
• Corporate Analysis
• Merck & Co., Inc.
• History and Lines of Business
• Financial Information
• Anti-Infective Drugs
• Research and Development
• Corporate Strategies
• Pfizer Inc.
• History and Lines of Business
• Financial Information
• Anti-Infective Drugs
• Research and Development
• Corporate Strategies
• Corporate Analysis
• SmithKline Beecham Pharmaceuticals
• History and Lines of Business
• Financial Information
• Anti-Infective Drugs
• Research and Development
• Corporate Strategies
• Corporate Analysis

Appendix: Company Names and Addresses

• Government Organization
• Manufacturers